15 Existing FDA-Approved Drugs Have The Potential To Treat Alzheimer’s Disease

According to preliminary study results, 15 existing drugs approved by the U.S. Food and Drug Administration (FDA) have the potential to slow or reverse brain damage in those with Alzheimer’s disease (AD) and another 14 for Parkinson Disease, Lou Gehrig's disease (amyotrophic lateral sclerosis, or ALS) or stroke. These 15 existing drugs had been FDA-approved for other purposes, which would expedite clinical trials that would otherwise be put on hold due to needed approval.

The list of potential drugs was determined by referencing a list of proteins present in the brain, cerebrospinal fluid, and blood plasma . . .